Nuveen Asset Management, LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,534,926
-49.1%
100,076
-49.0%
0.00%0.0%
Q1 2024$4,982,871
-17.2%
196,176
-26.1%
0.00%
-50.0%
Q4 2023$6,015,686
+135.5%
265,476
+93.6%
0.00%
+100.0%
Q3 2023$2,554,304
-14.2%
137,107
+19.6%
0.00%0.0%
Q2 2023$2,978,659
+85469.1%
114,652
-5.4%
0.00%0.0%
Q1 2023$3,481
+68.5%
121,212
+73.7%
0.00%0.0%
Q4 2022$2,066
-99.8%
69,792
+27.6%
0.00%0.0%
Q3 2022$1,302,000
+5.0%
54,713
-1.5%
0.00%
Q2 2022$1,240,000
-21.8%
55,565
-5.8%
0.00%
-100.0%
Q1 2022$1,585,000
-26.6%
59,014
+0.9%
0.00%0.0%
Q4 2021$2,159,000
-12.6%
58,486
-6.1%
0.00%0.0%
Q3 2021$2,471,000
-37.9%
62,271
-32.3%
0.00%0.0%
Q2 2021$3,981,000
+50.9%
91,951
+42.1%
0.00%0.0%
Q1 2021$2,639,000
-11.1%
64,697
-1.4%
0.00%0.0%
Q4 2020$2,969,000
+24.3%
65,612
-2.8%
0.00%0.0%
Q3 2020$2,388,000
+0.9%
67,476
+7.6%
0.00%0.0%
Q2 2020$2,366,000
+53.1%
62,715
+17.3%
0.00%0.0%
Q1 2020$1,545,000
-80.2%
53,448
-64.5%
0.00%
-66.7%
Q4 2019$7,817,000
-32.7%
150,751
-28.8%
0.00%
-40.0%
Q3 2019$11,618,000
+407.8%
211,670
+275.8%
0.01%
+400.0%
Q2 2019$2,288,00056,3310.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Portolan Capital Management 217,105$10,058,0002.20%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 284,393$13,175,0000.88%
AMI ASSET MANAGEMENT CORP 183,494$8,501,0000.84%
CAPITAL MANAGEMENT CORP /VA 49,765$2,306,0000.74%
TFS CAPITAL LLC 105,839$4,904,0000.39%
Baltimore-Washington Financial Advisors, Inc. 24,390$1,130,0000.35%
OBERWEIS ASSET MANAGEMENT INC/ 27,600$1,279,0000.32%
Stephens Investment Management Group LLC 192,650$8,925,0000.27%
THOMPSON SIEGEL & WALMSLEY LLC 263,622$12,214,0000.24%
DIKER MANAGEMENT LLC 21,200$982,0000.22%
View complete list of ANIKA THERAPEUTICS INC shareholders